Promising results from a psilocybin proceedings suggest that psychedelic therapies for slump could assistance immoderate – but not each – radical who don't respond to accepted antidepressants
Health | Analysis 10 November 2021By Sam Wong
A psilocybin therapy proceedings therapy room. COMPASS Pathways
Is psychedelic medicine yet acceptable to unrecorded up to the hype? Yesterday, promising results were announced from the largest objective proceedings of psilocybin for slump to date. They suggest that, portion psilocybin therapy is acold from a panacea, it tin assistance immoderate radical for whom existent medicines are ineffective.
The survey was led by Compass Pathways, a UK-based institution that holds patents for 2 synthetic formulations of psilocybin, the progressive constituent successful magic mushrooms. It progressive 233 radical with treatment-resistant depression, meaning to beryllium eligible …
Existing subscribers, delight log in with your email code to nexus your relationship access.
Paid quarterly
Inclusive of applicable taxes (VAT)
English (US) ·